These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23020787)
1. Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug. Jin HE; Song B; Kim SB; Shim WS; Kim DD; Chong S; Chung SJ; Shim CK Xenobiotica; 2013 Apr; 43(4):355-67. PubMed ID: 23020787 [TBL] [Abstract][Full Text] [Related]
2. Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin. Vadlapatla RK; Vadlapudi AD; Kwatra D; Pal D; Mitra AK Int J Pharm; 2011 Nov; 420(1):26-33. PubMed ID: 21864659 [TBL] [Abstract][Full Text] [Related]
3. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2). Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ BMC Med; 2004 May; 2():16. PubMed ID: 15125776 [TBL] [Abstract][Full Text] [Related]
4. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells. Ye L; Yang X; Yang Z; Gao S; Yin T; Liu W; Wang F; Hu M; Liu Z Toxicol Lett; 2013 Feb; 216(2-3):86-99. PubMed ID: 23200901 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines. Mukkavilli R; Jadhav G; Vangala S Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222 [TBL] [Abstract][Full Text] [Related]
6. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine. Dahan A; Sabit H; Amidon GL Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874 [TBL] [Abstract][Full Text] [Related]
7. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Guo A; Marinaro W; Hu P; Sinko PJ Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101 [TBL] [Abstract][Full Text] [Related]
8. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil. Choi MK; Song IS J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210 [TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies. Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885 [TBL] [Abstract][Full Text] [Related]
10. Potential role of ATP-binding cassette transporters in the intestinal transport of rhein. Ye L; Lu L; Li Y; Zeng S; Yang X; Chen W; Feng Q; Liu W; Tang L; Liu Z Food Chem Toxicol; 2013 Aug; 58():301-5. PubMed ID: 23665409 [TBL] [Abstract][Full Text] [Related]
11. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs. Sha X; Fang X Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079 [TBL] [Abstract][Full Text] [Related]
12. Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2). Haslam IS; Wright JA; O'Reilly DA; Sherlock DJ; Coleman T; Simmons NL Drug Metab Dispos; 2011 Dec; 39(12):2321-8. PubMed ID: 21930826 [TBL] [Abstract][Full Text] [Related]
13. Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells. Li H; Jin HE; Kim W; Han YH; Kim DD; Chung SJ; Shim CK Pharm Res; 2008 Nov; 25(11):2601-12. PubMed ID: 18654741 [TBL] [Abstract][Full Text] [Related]
14. Black ginger extract and its active compound, 5,7-dimethoxyflavone, increase intestinal drug absorption via efflux drug transporter inhibitions. Boonnop R; Meetam P; Siangjong L; Tuchinda P; Thongphasuk P; Soodvilai S; Soodvilai S Drug Metab Pharmacokinet; 2023 Jun; 50():100500. PubMed ID: 36948091 [TBL] [Abstract][Full Text] [Related]
15. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1. Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434 [TBL] [Abstract][Full Text] [Related]
16. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35. Yu H; Hu YQ; Ip FC; Zuo Z; Han YF; Ip NY Biopharm Drug Dispos; 2011 Apr; 32(3):140-50. PubMed ID: 21271607 [TBL] [Abstract][Full Text] [Related]
17. Polysorbate 20 increases oral absorption of digoxin in wild-type Sprague Dawley rats, but not in mdr1a(-/-) Sprague Dawley rats. Nielsen CU; Abdulhussein AA; Colak D; Holm R Int J Pharm; 2016 Nov; 513(1-2):78-87. PubMed ID: 27601334 [TBL] [Abstract][Full Text] [Related]
18. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model. Schrickx J; Fink-Gremmels J J Vet Pharmacol Ther; 2007 Feb; 30(1):25-31. PubMed ID: 17217397 [TBL] [Abstract][Full Text] [Related]
20. Assessment and modulation of forsythiaside absorption with MDCKII cells and validation with in situ intestinal experiment. Li YX; Zhang RQ; Peng C Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):179-86. PubMed ID: 22430364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]